News | April 22, 2008

New Deficit Reduction Act Compliance Tool Launched

April 23, 2008 - Sentry Data Systems Inc. launched the DRA Tool, a reporting and claims editing module that supports the additional reporting requirements of Section 6002 of the Federal Deficit Reduction Act (DRA).

The DRA Tool is feature of the company’s Sentinel RCM pharmacy revenue cycle management product.

The Federal Deficit Reduction Act (DRA), Section 6002, requires Medicaid participating ambulatory care providers to report the National Drug Code (NDC) when billing for physician-administered medications on Medicaid claims. NDC numbers uniquely identify a pharmaceutical’s vendor, product and trade package size and are maintained by the FDA. The previously unreported NDC is now required on claims submitted to Medicaid in addition to the currently required CPT/HCPCs codes and units.

Sentry's DRA Tool automatically matches the correct 11 digit NDCs with appropriate outpatient procedure codes to allow for uninterrupted claims payment by a state’s Medicaid program. Tracking the 11 Digit NDC provides a new mechanism for individual states to maximize their Medicaid rebates from manufacturers and is financially critical for states and responsible entities, said Sentry.

“Sentinel RCM’s DRA Tool provides hospitals with immediate billing compliance by either electronically editing claims as they are submitted and by providing reports that comply with each state's individual requirements,” said Travis Leonardi RPh., C.P. president and founder of Sentry Data Systems.
Existing Sentinel RCM customers need only contact Sentry for activation.
For more information: www.sentryds.com

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...